AAAAAA

   
Results: 1-2 |
Results: 2
K-ras oncogene subtype mutations are associated with survival but not expression of p53, p16(INK4A), P21(WAF-1), cyclin D1, erbB-2 and erbB-3 in resected pancreatic ductal adenocarcinoma
Authors: Kawesha, A Ghaneh, P Andren-Sandberg, A Ograed, D Skar, R Dawiskiba, S Evans, JD Campbell, F Lemoine, N Neoptolemos, JP
Citation: A. Kawesha et al., K-ras oncogene subtype mutations are associated with survival but not expression of p53, p16(INK4A), P21(WAF-1), cyclin D1, erbB-2 and erbB-3 in resected pancreatic ductal adenocarcinoma, INT J CANC, 89(6), 2000, pp. 469-474
Adjuvant therapy for pancreatic cancer
Authors: Ghaneh, P Kawesha, A Howes, N Jones, L Neoptolemos, JP
Citation: P. Ghaneh et al., Adjuvant therapy for pancreatic cancer, WORLD J SUR, 23(9), 1999, pp. 937-945
Risultati: 1-2 |